Human epidermal growth factor receptor 2 (HER2) expression and/or gene amplification can be found in a subset of ovarian cancer (in up to 30%–40%), depending on the cutoff for receptor positivity [72, 73, 74]. Here, ERBB2 is linked to ovarian carcinoma.